{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:21:49Z","timestamp":1770268909522,"version":"3.49.0"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,8,31]]},"DOI":"10.18632\/aging.203475","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T13:59:46Z","timestamp":1630331986000},"page":"20793-20807","source":"Crossref","is-referenced-by-count":7,"title":["Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma"],"prefix":"10.18632","volume":"13","author":[{"given":"Guo","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing 400030, China"},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing 400030, China"},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing 400030, China"},{"name":"Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019.","volume":"6","author":"Jemal","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","article-title":"Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.","volume":"3","author":"Myers","year":"2015","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis.","volume":"2","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-319-30654-4_11","article-title":"Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model.","volume":"91","author":"Snaar-Jagalska","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa326","article-title":"Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness.","author":"Sowers","year":"2020","journal-title":"Cardiovasc Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4174\/astr.2015.89.1.1","article-title":"Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis.","volume":"8","author":"Baek","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"e000696","DOI":"10.1136\/jitc-2020-000696","article-title":"Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial.","volume":"8","author":"Song","year":"2020","journal-title":"J Immunother Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10456-020-09716-y","article-title":"Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.","volume":"2","author":"Yao","year":"2020","journal-title":"Angiogenesis"},{"key":"9","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/1078-0432.CCR-20-2571","article-title":"Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial.","volume":"2","author":"Xiong","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1158\/1078-0432.CCR-20-3136","article-title":"Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy.","volume":"2","author":"Yu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ygyno.2017.12.013","article-title":"A phase II study of apatinib in patients with recurrent epithelial ovarian cancer.","volume":"14","author":"Tang","year":"2018","journal-title":"Gynecol Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41388-020-01545-z","article-title":"Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma.","volume":"4","author":"Lai","year":"2021","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41591-018-0007-9","article-title":"Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.","volume":"2","author":"Nilsson","year":"2018","journal-title":"Nat Med"},{"key":"14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.celrep.2019.09.004","article-title":"Functional Redundancy between \u03b21 and \u03b23 Integrin in Activating the IR\/Akt\/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer.","volume":"2","author":"Muller","year":"2019","journal-title":"Cell Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1158\/1078-0432.CCR-17-3674","article-title":"ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy.","volume":"2","author":"Seshagiri","year":"2018","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2.","volume":"3","author":"Zhang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.gastro.2013.10.011","article-title":"Autocrine VEGF signaling promotes proliferation of neoplastic Barrett\u2019s epithelial cells through a PLC-dependent pathway.","volume":"14","author":"Wang","year":"2014","journal-title":"Gastroenterology"},{"key":"18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.21203\/rs.3.rs-30028\/v1","article-title":"A therapeutic approach with combination of interferon-gamma and autophagy inhibitor for oral squamous cell carcinoma.","volume":"1","author":"Zhong","year":"2021","journal-title":"Am J Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.3892\/ol.2018.8031","article-title":"Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K\/Akt pathway.","volume":"1","author":"Yu","year":"2018","journal-title":"Oncol Lett"},{"key":"20","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1038\/cddis.2017.422","article-title":"Apatinib promotes autophagy and apoptosis through VEGFR2\/STAT3\/BCL-2 signaling in osteosarcoma.","volume":"8","author":"Guo","year":"2017","journal-title":"Cell Death Dis"},{"key":"21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12951-021-00901-9","article-title":"Overcoming chemotherapy resistance using pH-sensitive hollow MnOnanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma.","volume":"1","author":"Zhong","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"22","doi-asserted-by":"publisher","first-page":"10122","DOI":"10.12659\/MSM.919610","article-title":"MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)\/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer.","volume":"2","author":"Hu","year":"2019","journal-title":"Med Sci Monit"},{"key":"23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/1759-7714.13726","article-title":"Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K\/AKT apoptosis-inhibiting pathway.","volume":"1","author":"Wang","year":"2021","journal-title":"Thorac Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41419-020-2352-0","article-title":"Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7.","volume":"1","author":"Zhou","year":"2020","journal-title":"Cell Death Dis"},{"key":"25","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1200\/JCO.2016.69.6179","article-title":"Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.","volume":"3","author":"Yuan","year":"2017","journal-title":"J Clin Oncol"},{"key":"26","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.20.02751","article-title":"Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.","volume":"3","author":"Takashima","year":"2021","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10120-020-01126-9","article-title":"Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor\/c-kit signaling and its downstream pathways.","volume":"2","author":"Yuan","year":"2021","journal-title":"Gastric Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1365-2133.2010.09947.x","article-title":"Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours.","volume":"16","author":"Pujol","year":"2010","journal-title":"Br J Dermatol"},{"key":"29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.","volume":"4","author":"Gajewski","year":"2014","journal-title":"Immunity"},{"key":"30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10875-021-00974-z","article-title":"STING-Mediated Lung Inflammation and Beyond.","volume":"4","author":"Crow","year":"2021","journal-title":"J Clin Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1074\/jbc.RA118.002175","article-title":"Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D.","volume":"29","author":"Kosako","year":"2018","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1128\/AAC.00771-17","article-title":"Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.","volume":"6","author":"Guo","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"33","doi-asserted-by":"publisher","first-page":"e0187532","DOI":"10.1371\/journal.pone.0187532","article-title":"STING expression and response to treatment with STING ligands in premalignant and malignant disease.","volume":"1","author":"Gough","year":"2017","journal-title":"PLoS One"},{"key":"34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-14-3619","article-title":"Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors.","volume":"7","author":"Gough","year":"2016","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"eaba6098","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with antitumor activity.","volume":"36","author":"Chen","year":"2020","journal-title":"Science"},{"key":"36","doi-asserted-by":"publisher","first-page":"e20200844","DOI":"10.1084\/jem.20200844","article-title":"STING agonist promotes CAR T cell trafficking and persistence in breast cancer.","volume":"21","author":"Serody","year":"2021","journal-title":"J Exp Med"},{"key":"37","doi-asserted-by":"publisher","first-page":"e001182","DOI":"10.1136\/jitc-2020-001182","article-title":"Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity.","volume":"8","author":"Mellor","year":"2020","journal-title":"J Immunother Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-019-1123-y","article-title":"A novel IFN\u03b1-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma.","volume":"1","author":"Jin","year":"2020","journal-title":"Mol Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2019.02.052","article-title":"Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma.","volume":"45","author":"Hu","year":"2019","journal-title":"Cancer Lett"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T16:13:08Z","timestamp":1630944788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":39,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021,8,31]]}},"alternative-id":["203475","34459788"],"URL":"https:\/\/doi.org\/10.18632\/aging.203475","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}